1. Home
  2. NTST vs VRDN Comparison

NTST vs VRDN Comparison

Compare NTST & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTST
  • VRDN
  • Stock Information
  • Founded
  • NTST 2019
  • VRDN 2006
  • Country
  • NTST United States
  • VRDN United States
  • Employees
  • NTST N/A
  • VRDN N/A
  • Industry
  • NTST Real Estate Investment Trusts
  • VRDN Medical Specialities
  • Sector
  • NTST Real Estate
  • VRDN Health Care
  • Exchange
  • NTST Nasdaq
  • VRDN Nasdaq
  • Market Cap
  • NTST 1.3B
  • VRDN 1.3B
  • IPO Year
  • NTST 2020
  • VRDN N/A
  • Fundamental
  • Price
  • NTST $18.30
  • VRDN $17.41
  • Analyst Decision
  • NTST Strong Buy
  • VRDN Strong Buy
  • Analyst Count
  • NTST 10
  • VRDN 10
  • Target Price
  • NTST $18.53
  • VRDN $38.11
  • AVG Volume (30 Days)
  • NTST 1.7M
  • VRDN 684.1K
  • Earning Date
  • NTST 07-23-2025
  • VRDN 08-15-2025
  • Dividend Yield
  • NTST 4.70%
  • VRDN N/A
  • EPS Growth
  • NTST N/A
  • VRDN N/A
  • EPS
  • NTST N/A
  • VRDN N/A
  • Revenue
  • NTST $179,740,000.00
  • VRDN $302,000.00
  • Revenue This Year
  • NTST $12.97
  • VRDN N/A
  • Revenue Next Year
  • NTST $6.22
  • VRDN $17,102.33
  • P/E Ratio
  • NTST N/A
  • VRDN N/A
  • Revenue Growth
  • NTST 21.39
  • VRDN 4.86
  • 52 Week Low
  • NTST $13.42
  • VRDN $9.90
  • 52 Week High
  • NTST $18.93
  • VRDN $27.20
  • Technical
  • Relative Strength Index (RSI)
  • NTST 65.23
  • VRDN 58.43
  • Support Level
  • NTST $18.17
  • VRDN $16.65
  • Resistance Level
  • NTST $18.80
  • VRDN $18.80
  • Average True Range (ATR)
  • NTST 0.43
  • VRDN 0.81
  • MACD
  • NTST 0.02
  • VRDN -0.03
  • Stochastic Oscillator
  • NTST 62.58
  • VRDN 50.97

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: